Janney Montgomery Scott
KITE

Janney Montgomery Scott’s Kite Pharma, Inc. KITE Stock Holding History

Janney Montgomery Scott’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-4,300
Closed -$239K – 1474
2015
Q3 		$239K Buy
+4,300
New +$270K 0.01% 1160

Other funds holding KITE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WCM
Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Janney Montgomery Scott's KITE Position: Q4 2015 in Review

Janney Montgomery Scott sold out of Kite Pharma, Inc. (KITE) in Q4 2015, closing a stake of 4,300 shares — an estimated $239K sold.

Janney Montgomery Scott first reported a position in KITE in Q3 2015 and held it in 1 quarter. The position peaked at $239K in Q3 2015. 187 funds tracked by Wall St. Rank hold KITE as of Q4 2015.

  • Janney Montgomery Scott reported no remaining Kite Pharma, Inc. position as of Q4 2015 after selling out during the quarter.
  • Janney Montgomery Scott sold 4,300 Kite Pharma, Inc. shares in Q4 2015, an estimated $239K.
  • Janney Montgomery Scott first reported a position in Kite Pharma, Inc. in Q3 2015 and held it in 1 quarter.
  • Janney Montgomery Scott's Kite Pharma, Inc. position peaked at $239K in Q3 2015.
  • 187 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2015.

Based on Janney Montgomery Scott's 13F filing for Q4 2015, filed 19 Feb 2016.